Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Viridian Therapeutics, Inc.

24.29
-0.2100-0.86%
Pre-market: 24.360.0675+0.28%09:11 EDT
Volume:906.30K
Turnover:22.04M
Market Cap:2.75B
PE:-7.02
High:24.75
Open:24.65
Low:24.07
Close:24.50
52wk High:34.29
52wk Low:13.18
Shares:113.29M
Float Shares:108.00M
Volume Ratio:0.57
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4579
EPS(LYR):-3.3245
ROE:-65.74%
ROA:-30.16%
PB:4.88
PE(LYR):-7.31

Loading ...

OverviewCompanyNewsFilings

Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study. -- Barrons.com

Dow Jones
·
Apr 07

BUZZ-Viridian slides as Amgen data raises competition fears

Reuters
·
Apr 06

Viridian sinks after Amgen thyroid eye disease study hits endpoints

TIPRANKS
·
Apr 06

Analysts Offer Insights on Healthcare Companies: Pelthos Therapeutics (PTHS), IDEAYA Biosciences (IDYA) and Viridian Therapeutics (VRDN)

TIPRANKS
·
Apr 06

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Apr 06

Evercore cuts Viridian price target, removes from ‘Tactical Outperform’ list

TIPRANKS
·
Apr 02

Viridian Therapeutics Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Mar 31

Viridian Therapeutics Inc : Wedbush Cuts Target Price to $37 From $44

THOMSON REUTERS
·
Mar 31

U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks

Reuters
·
Mar 31

4D Molecular Therapeutics names CFO Kristian Humer principal accounting officer

Reuters
·
Mar 31

Top Midday Decliners

MT Newswires Live
·
Mar 31

BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar

Reuters
·
Mar 30

Top Midday Stories: Trump Touts Talks With New Iranian Regime, Renews Threats; Sysco to Acquire Jetro for $29.1 Billion

MT Newswires Live
·
Mar 30

Analysts Offer Insights on Healthcare Companies: Lipocine (LPCN), Viridian Therapeutics (VRDN) and Incyte (INCY)

TIPRANKS
·
Mar 30

Viridian Therapeutics falls -33.5%

TIPRANKS
·
Mar 30

BUZZ-U.S. STOCKS ON THE MOVE-Insmed, United Therapeutics, CrowdStrike

Reuters
·
Mar 30

Viridian Therapeutics down 37% after announcing results from elegrobart trial

TIPRANKS
·
Mar 30

Viridian Therapeutics Exec Says Company Is Sufficiently Funded to Support Operations Through Profitability – Conf Call

THOMSON REUTERS
·
Mar 30

Viridian Therapeutics Exec Says Co Has a Lot of Pricing 'Optionality' for Elegrobart After Late-Stage Data – Conf Call

THOMSON REUTERS
·
Mar 30

Top Premarket Decliners

MT Newswires Live
·
Mar 30
More